Business Health

According to a recent report by KDMI, Multiplex Assay Market is anticipated to Boom by 2026

Press Release

KD Market Insights has published a new report on  Multiplex Assay Market analysis and forecast 2019-2026. The report comprises of Multiplex Assay Market size, Y-o-Y growth analysis, and market dynamics, including growth drivers, restraining factors, opportunities, and trends which are spearheading current nature and future status of the market.

The global multiplex assays market accounted for $73.2 million in 2018, and is expected to reach $123.1 million by 2026, growing at a CAGR of 6.6% from 2019 to 2026.

Multiplex immunoassays conjugates assays for several target analytes in a single reaction volume, minimizing workflow and sample volume difficulties. In addition, this assay provides a gain in assay dynamic range, and is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as singleplex ELISA. Multiplex assays find its application in pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.


Request for Sample @

Multiplex assays hold enormous potential in the R&D of drugs for the treatment of diseases, such as cancer and cardiovascular diseases that drives the market growth for theses assays. For instance, bead based Luminex xMAP multiplex assay provides a platform for cancer biomarker assays, which are compatible with plasma, serum, cultured cells, and other biological samples. In addition, surge in adoption of multiplex assays to reduce operation costs and rise in adoption of personalized medicines are anticipated to boost the market growth. However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth. On the contrary, the emerging economies of Asia-Pacific and LAMEA regions offer lucrative growth opportunities for the expansion of multiplex assays market, due to improvement in healthcare infrastructure in these regions and increase in demand for better healthcare services from majority of the patient population.

The global multiplex assays market in this report is studied based on type, product, technology, application, end user, and region. On the basis of type, the market is divided into nucleic acid-based, protein-based multiplex assays, and others. By product, it is classified into multiplex assay reagents & consumables, multiplex assay instruments & accessories, and multiplex assay software & services. Depending on technology, it is fragmented into nucleic acid-based, protein-based multiplex assays, and others. As per application, it is segregated into companion diagnostics, research & development, clinical diagnostics, and others. According to end user, it is classified into hospitals, clinical laboratories, research institutes, and pharmaceuticals & biotechnological companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


– The study provides an in-depth analysis of the global multiplex assay market along with the current trends and future estimations to elucidate the imminent investment pockets.
– A comprehensive analysis of the factors that drive and restrict the market growth is provided.
– A comprehensive quantitative analysis of the industry is provided from 2018 to 2025 to assist stakeholders to capitalize on the prevailing market opportunities.
– An extensive analysis of the key segments of the industry helps to understand the global trends in the multiplex assay market.
– Key players and their strategies are provided to understand the competitive outlook of the industry.


By Type
– Nucleic Acid-based Multiplex Assays
– Protein-based Multiplex Assays
– Others

By Product
– Multiplex Assay Reagents & Consumables
– Multiplex Assay Instruments & Accessories
– Multiplex Assay Software & Services

By Technology
– Multiplex PCR
– Multiplex Protein Microarray
– Others

By Application
– Companion Diagnostics
– Research & Development
– Clinical Diagnostics

By End User
– Hospitals
– Clinical Laboratories
– Research Institutes
– Pharmaceuticals & Biotechnological Companies

By Region

North America
– U.S.
– Canada
– Mexico
– UK
– France
– Germany
– Italy
– Spain
– Rest of Europe
– Japan
– China
– India
– South Korea
– Australia
– Rest of Asia-Pacific
– Saudi Arabia
– South Africa
– Brazil
– Rest of LAMEA


– Luminex Corporation
– Thermo Fisher Scientific Inc.
– Illumina Inc.
– Bio-Rad Laboratories Inc.
– Becton, Dickinson and Company
– Abcam PLC
– Seegene Inc.
– Randox Laboratories Ltd.

The other players in the value chain include (profiles not included in the report)

– Merck KGaA
– Agilent Technologies
– Quanterix
– Olink
– Sysmex Corporation
– Siemens Healthcare GmbH
– F. Hoffmann-La Roche Ltd.
– Johnson & Johnson


Browse Full Report With [email protected]

Table of Content


1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst Tools and Models


2.1. Key findings of the study
2.2. CXO perspective


3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Moderate bargaining power of buyers
3.3.2. Low bargaining power of suppliers
3.3.3. Moderate threat of substitutes
3.3.4. Low threat of new entrants
3.3.5. Moderate competitive rivalry

3.4. Market share analysis, 2018
3.5. Market dynamics

3.5.1. Drivers Increase in R&D activities & governmental funding Surge in adoption of multiplex assays to reduce operation costs Rise in adoption of personalized medicines

3.5.2. Restraint Lack of skilled labor/healthcare professionals

3.5.3. Opportunity Various growth opportunities in emerging economies


4.1. Overview

4.1.1. Market size and forecast

4.2. Nucleic acid-based multiplex assays

4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market share analysis, by country

4.3. Protein-based multiplex assays

4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market share analysis, by country

4.4. Others

4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market share analysis, by country


5.1. Overview

5.1.1. Market size and forecast

5.2. Multiplex assays reagents & consumables

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast
5.2.3. Market share analysis, by country

5.3. Multiplex assays instruments & accessories

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast
5.3.3. Market share analysis, by country

5.4. Multiplex assay software & services

5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast
5.4.3. Market share analysis, by country


Check for Discount @

About KD Market Insights

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: [email protected]


Read More News:

About the author


Jason Lee